Sep 7, 2025, 13:37
Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
RPTH Journal shared on LinkedIn:
”ECMO is life-saving technology!
What is better for patient outcomes? This review compares low dose vs standard unfractionated heparin on patient morbidity and mortality.”
Read the full article here.
Article: Mortality and Complications in Low-Dose versus Standard-Dose Unfractionated Heparin Anticoagulation for Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Authors: Wincy Wing-Sze Ng, Rex Wan-Hin Hui, Ka-Chun Leung, Pauline Yeung Ng, Chun-Wai Ngai, Simon Wai-Ching Sin, Chun-Fung Sin
Stay updated on the latest scientific advances in the field of coagulation with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp